Generic Name |
Apatinib Mesylate | |
---|---|---|
IND |
YN968D1 | |
Brand Name (US) |
Rivoceranib | |
Manufacturer |
Jiangsu Hengrui Medicine | |
Drug Type |
Tyrosine Kinase Inhibitor | |
Delivery |
Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
||
Strategy |
||
Drug Category |
VEGFR2 Inhibitor |